A GBM patient share his story – Case report
When we were at the beginning with ‘TRIAL-IN Pharma’, I.C.’s son approached us and asked whether we can help his dad, a 58 years old
Breakthrough cancer drug for metastatic urothelial cancer patients
Two weeks ago, results from Phase I/II study in which patients with metastatic urothelial cancer – whose disease progressed after platinum-based standard chemotherapy and after
Dear A.G., Metastatic Breast Cancer Patient – Case Study
About A.G. A.G. turned to us about two months ago and told us that her doctor, from a large medical center in the center of
Genetic mutations for pancreatic cancer patients
The NCCN is the organization that sets the guidelines in the United States for the treatment of various types of cancer, and is composed of
Biological drugs for metastatic gastric cancer patients
About a week ago, the International Conference on Gastrointestinal Tracts was held in the United States. The conference presented results from a Phase I /
Genetic testing for cancer patients
Personalized medicine has led to some dramatic successes in the treatment of cancer in patients with advanced disease. With developments in molecular diagnosis or genetic
Drug from abroad for Glioblastoma, GBM, patients
A drug called Apatinib® (Rivoceranib), is approved in China, South Korea and Europe for gastric cancer but not for GBM. Why is it related to
Osteosarcoma patients and Ewing sarcoma patients, this post can help you
What did Cabometix® demonstrate? Two drugs, Cabometix® (Cabozantinib) and Stivarga® (Regorafenib) are approved for various indications and are now breakthroughs in the treatment of advanced
Innovative treatment for pancreatic cancer
Pancreatic cancer is known as a particularly cruel cancer. Radiation into the tumor itself may be part of the treatment plan but these radiation protocols
New clinical study opens to recruit stage 4 metastatic pancreatic cancer patients
Will a new hope with an advanced drug for the treatment of stage 4 metastatic pancreatic cancer patients prove itself in a new study that
A breakthrough CAR-T therapy for metastatic pancreatic cancer patients
Metastatic Stage 4 pancreatic cancer patients, you should read and inform your oncologist. What is CAR-T? CAR-T therapy is an innovative treatment strategy based on
